推薦產品
product name
羟基脲, 98%, powder
化驗
98%
形狀
powder
顏色
white
溶解度
H2O: 50 mg/mL
儲存溫度
2-8°C
SMILES 字串
NC(=O)NO
InChI
1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)
InChI 密鑰
VSNHCAURESNICA-UHFFFAOYSA-N
基因資訊
human ... CA1(759) , CA2(760) , CYP1A2(1544) , RRM1(6240) , RRM2(6241) , RRM2B(50484)
尋找類似的產品? 前往 產品比較指南
一般說明
Hydroxyurea is a hydroxylated analog of urea. It is beneficial in increasing fetal hemoglobin (HbF) levels, which in turn reduces the frequency of severe crises and the need for blood transfusions in sickle cell anemia patients. Hydroxyurea exhibits cell-cycle specificity for the S phase, leading to cell arrest at G1 to S. This non-alkylating S phase-specific myelosuppressive agent has a mechanism of action that is not specific to platelets.
應用
羟基脲用于:
- MCF-7人乳腺肿瘤细胞、分裂酵母、苗木主根中的细胞周期同步化
- 在细胞活性和细胞周期实验中,治疗Leishmania mexicana寄生虫
- 在Caki对照和CD9下调细胞的细胞粘附和迁移检测实验中,用作抑制剂
生化/生理作用
抗肿瘤剂。通过形成自由基硝基氧灭活核糖核苷还原酶,自由基硝基氧可结合到酶活性位点的酪氨酰自由基。这可阻断脱氧核苷酸的合成,从而抑制 DNA 合成,并且诱导细胞周期同步化或 S-期细胞死亡。
特點和優勢
该化合物是细胞凋亡研究的特色产品。点击此处 ,查看更多细胞凋亡精选产品。想要了解有关生物活性小分子在其他研究领域应用的更多信息,请访问sigma.com/discover-bsm。
訊號詞
Danger
危險聲明
危險分類
Muta. 1B - Repr. 2
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Flow cytometric chromosome sorting in plants: the next generation
Methods, 57(3), 331-337 (2012)
Protein tyrosine nitration in the cell cycle
Biochemical and Biophysical Research Communications, 413(2), 270-276 (2011)
Activity of hydroxyurea against Leishmania mexicana
Antimicrobial Agents and Chemotherapy, 52(10), 3642-3647 (2008)
The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma
Biochemical and Biophysical Research Communications, 471(1), 21-25 (2016)
British journal of haematology, 161(5), 688-694 (2013-04-12)
Givinostat, a histone-deacetylase inhibitor (HDACi), inhibits proliferation of cells bearing the JAK2 V617F mutation and has shown significant activity with good tolerability in patients with chronic myeloproliferative neoplasms (MPN). In this multicentre, open-label, phase II study, 44 patients with polycythaemia
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務